| Regal Partners Global Investments Limited (RG1) ORDINARY FULLY PAID |
Financials |
$552 |
Update - Notification of buy-back - RG1
|
12 May 2026 9:03AM |
$2.220 |
$2.380 |
risen by
7.21%
|
|
| Cogstate Limited (CGS) ORDINARY FULLY PAID |
Health Care |
$620 |
Update - Notification of buy-back - CGS
|
12 May 2026 9:02AM |
$2.500 |
$3.600 |
risen by
44%
|
|
| REA Group Ltd (REA) ORDINARY FULLY PAID |
Communication Services |
$21,729 |
Update - Notification of buy-back - REA
|
12 May 2026 9:01AM |
$177.560 |
$166.050 |
fallen by
6.48%
|
|
| Carlton Investments Limited (CIN) ORDINARY FULLY PAID |
Financials |
$898 |
Update - Notification of buy-back - CIN
|
12 May 2026 9:00AM |
$33.470 |
$34.100 |
risen by
1.88%
|
|
| Australian Clinical Labs Limited (ACL) ORDINARY FULLY PAID |
Health Care |
$545 |
Update - Notification of buy-back - ACL
|
12 May 2026 9:00AM |
$1.930 |
$2.920 |
risen by
51.30%
|
|
| Fluence Corporation Limited (FLC) ORDINARY FULLY PAID |
Utilities |
$70 |
FLC Wins Strategic $3.7M Industrial Water Contract in US
|
12 May 2026 8:58AM |
$0.082 |
$0.061 |
fallen by
25.61%
|
|
FLC - Price-sensitive ASX Announcement
Full Release
Key Points
- Fluence secures $3.7M contract in Texas
- Involves ultrafiltration and reverse osmosis
- Facility to produce 1.5M gallons daily
- Reduces reliance on municipal water
- Project operational by end of 2026
- Addresses water scarcity in Texas
- Reflects trend towards sustainable water management
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EBR Systems Inc (EBR) CDI 10:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$118 |
Q1 2026 Quarterly Activity Report and Form 10-Q Submission
|
12 May 2026 8:57AM |
$0.600 |
$0.140 |
fallen by
76.67%
|
|
EBR - Price-sensitive ASX Announcement
Full Release
Key Points
- EBR Systems Inc. continued its commercialization efforts for the WiSE CRT System in the US, with commercial case volumes more than doubling in Q1 2026 compared to Q4 2025.
- The WiSE CRT System was implanted in 41 commercial patients during Q1 2026, taking the total to 71 implants across the pilot launch phase and Limited Market Release.
- Additional 16 purchase agreements were signed with target centers, building on 21 from prior quarters.
- EBR Systems received Priority Review Determination from the TGA for the WiSE CRT System, expediting its regulatory review in Australia.
- Net operating cash outflows for the quarter were US$20.3m, influenced by annual bonuses, payroll taxes, and WiSE demo and testing unit charges.
- The company reported a gross margin of 7.8%, which included favorable impacts from previously expensed inventory.
- Revenue from the WiSE CRT System was US$2.32 million for Q1 2026.
- EBR Systems maintained an active presence in investor and healthcare conferences to boost communication on FDA approval and commercialization progress.
- No material adverse legal proceedings were reported, and no changes were made to risk factors from previous disclosures.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BETR Entertainment Limited (BBT) ORDINARY FULLY PAID |
Consumer Discretionary |
$142 |
Update - Notification of buy-back - BBT
|
12 May 2026 8:54AM |
$0.180 |
$0.135 |
fallen by
25%
|
|
| Dexus Industria REIT (DXI) FULLY PAID ORDINARY/UNITS STAPLED SECURITIES |
Real Estate |
$722 |
Update - Notification of buy-back - DXI
|
12 May 2026 8:54AM |
$2.450 |
$2.340 |
fallen by
4.49%
|
|
| Orion Minerals Ltd (ORN) ORDINARY FULLY PAID |
Materials |
$219 |
Drilling Extends Significant Copper Mineralisation at Okiep
|
12 May 2026 8:54AM |
$0.029 |
$0.025 |
fallen by
15.52%
|
|
ORN - Price-sensitive ASX Announcement
Full Release
Key Points
- Drill hole OFMED157 intersects 7.88m of significant visible copper mineralisation.
- OFMED157 located 36m down-dip from a previous high-grade intersection in OFMED154.
- Continued drilling shows potential for extending mineralisation beyond current resource envelope.
- Flat Mines area key to Orion's Okiep development strategy with strong resource growth potential.
- Assay results from drill hole OFMND244 at Flat Mine North include 21.34m at 1.55% Cu.
- Further drilling planned to explore down-dip extensions at Flat Mine East.
- Assay results for ongoing drilling expected in approximately three weeks.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$226 |
Change of Director's Interest Notice
|
12 May 2026 8:54AM |
$0.955 |
$0.830 |
fallen by
13.09%
|
|
| Altitude Minerals Ltd (ATT) ORDINARY FULLY PAID |
Materials |
$2 |
Exploration and Corporate Update May 2026
|
12 May 2026 8:52AM |
$0.013 |
$0.004 |
fallen by
69.23%
|
|
| Barton Gold Holdings Limited (BGD) ORDINARY FULLY PAID |
Materials |
$226 |
Application for quotation of securities - BGD
|
12 May 2026 8:52AM |
$0.955 |
$0.830 |
fallen by
13.09%
|
|
| Capricorn Metals Ltd (CMM) ORDINARY FULLY PAID |
Materials |
$6,149 |
Change of Director's Interest Notice
|
12 May 2026 8:51AM |
$13.410 |
$13.450 |
risen by
0.30%
|
|
| True North Copper Limited (TNC) ORDINARY FULLY PAID |
Materials |
$46 |
Cloncurry drilling completed for 2026 PFS
|
12 May 2026 8:51AM |
$0.420 |
$0.240 |
fallen by
42.86%
|
|
| Solvar Limited (SVR) ORDINARY FULLY PAID |
Financials |
$259 |
Shaw & Partners Emerging Companies Conference
|
12 May 2026 8:51AM |
$1.505 |
$1.385 |
fallen by
7.97%
|
|
| Dexus Convenience Retail REIT (DXC) FULLY PAID UNITS STAPLED SECURITIES |
Real Estate |
$365 |
Update - Notification of buy-back - DXC
|
12 May 2026 8:50AM |
$2.750 |
$2.720 |
fallen by
1.09%
|
|
| Alvo Minerals Limited (ALV) ORDINARY FULLY PAID |
Materials |
$28 |
Update - Proposed issue of securities - ALV
|
12 May 2026 8:50AM |
$0.042 |
$0.084 |
risen by
100%
|
|
| Tennant Minerals Limited (TMS) ORDINARY FULLY PAID |
Materials |
$10 |
Response to ASX Price Query
|
12 May 2026 8:50AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
TMS - Price-sensitive ASX Announcement
Full Release
Key Points
- TMS's securities price increased from $0.007 to $0.012 on 7th May 2026.
- TMS was unaware of any unannounced information affecting trade on 7th May 2026.
- Re-assay results of 26 samples from drillhole BBDD0050 received on 8th May 2026.
- Initial assay results from BBDD0050 were released on 1st May 2026.
- Re-assays were carried out due to visible gold and native copper.
- The re-assay results were not materially different from the original results.
- TMS maintained confidentiality using secure digital communications until public announcements.
- An announcement about the re-assay results was made on 12th May 2026.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ansell Limited (ANN) ORDINARY FULLY PAID |
Health Care |
$6,421 |
Update - Notification of buy-back - ANN
|
12 May 2026 8:50AM |
$26.250 |
$45.760 |
risen by
74.32%
|
|
| Tennant Minerals Limited (TMS) ORDINARY FULLY PAID |
Materials |
$10 |
Re-Assays Confirm Exceptional Bluebird Au-Bi-Cu Drill Hit
|
12 May 2026 8:50AM |
$0.010 |
$0.007 |
fallen by
30%
|
|
TMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Tennant Minerals Limited has confirmed exceptional gold, bismuth, and copper grades in the Bluebird discovery.
- Re-assay results from diamond drill-hole BBDD0050 show high-grade mineralization, including 18m at 10.0 g/t AuEq.
- Spectacular grades of 47.2 g/t gold, 12.0% bismuth, and 9.3% copper were reported.
- The high-grade zone has been extended to the west and below the announced open-pit Mineral Resource.
- Preparations are underway for an expanded drilling program funded by a $2.8 million capital raise.
- The Bluebird discovery remains open to the west, indicating potential to expand the mineralized zone significantly.
- The company has applied for co-funding from the Northern Territory government for further exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Enlitic Inc (ENL) CHESS DEPOSITARY INTERESTS 1:1 US PROHIBITED |
Health Care |
$25 |
Ensight go-live at NZs largest private radiology provider
|
12 May 2026 8:50AM |
$0.011 |
$0.034 |
risen by
209.09%
|
|
ENL - Price-sensitive ASX Announcement
Full Release
Key Points
- Ensight platform go-live at RHCNZ Medical Imaging Group in New Zealand.
- First production deployment of Enlitic's integration with Intelerad's IntelePACS.
- Ensight standardizes imaging study presentations to improve efficiency.
- Follows a record Q1 FY26 for Enlitic with significant contract wins.
- Strategic partnership with RHCNZ for market expansion.
- Potential for additional Ensight use cases identified.
- RHCNZ deployment provides a strong reference in the Intelerad channel.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| 4DS Memory Limited (4DS) ORDINARY FULLY PAID |
Information Technology |
$14 |
Company Update
|
12 May 2026 8:49AM |
$0.011 |
$0.005 |
fallen by
54.55%
|
|
4DS - Price-sensitive ASX Announcement
Full Release
Key Points
- 4DS is advancing commercialisation of its proven 60nm ReRAM platform in South East Asia, particularly India.
- The company sees its strongest near-term opportunity in mature-node applications across industrial, automotive, defence, aerospace and embedded markets.
- India has committed more than AUD$25 billion to develop a sovereign semiconductor manufacturing industry.
- India’s current fabrication capability is focused on mature-node technologies including the 60nm–65nm range already demonstrated by 4DS.
- 4DS recently announced its intention to pursue an acquisition to support product integration and commercial deployment pathways.
- Commercial pathways identified include semiconductor licensing and technology transfer aligned with India’s fabrication roadmap.
- Additional pathways include embedded memory applications in industrial, aerospace, defence and infrastructure systems.
- 4DS also highlighted R&D partnerships for edge AI and memory-centric computing architectures.
- OEM integration pathways are expected to be supported through software, SDK and systems capability.
- Executive Chairman David McAuliffe will travel to India in May 2026 with technical support to engage stakeholders as part of the commercialisation strategy.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Wisr Limited (WZR) ORDINARY FULLY PAID |
Financials |
$62 |
Shaw and Partners Small Cap Financials Conference
|
12 May 2026 8:47AM |
$0.020 |
$0.035 |
risen by
75%
|
|
| Brainchip Holdings Ltd (BRN) ORDINARY FULLY PAID |
Information Technology |
$250 |
Change of Director's Interest Notice - Hehir
|
12 May 2026 8:46AM |
$0.155 |
$0.110 |
fallen by
29.03%
|
|